CAC
Cowen and Company Portfolio holdings
AUM
$2.9B
This Quarter Return
+0.2%
1 Year Return
+104.28%
3 Year Return
+119.87%
5 Year Return
+632.2%
10 Year Return
–
AUM
$850M
AUM Growth
+$850M
(-9.9%)
Cap. Flow
+$36.1M
Cap. Flow
% of AUM
4.25%
Top 10 Holdings %
Top 10 Hldgs %
47.61%
Holding
780
New
163
Increased
153
Reduced
170
Closed
202
Top Buys
| 1 |
scPharmaceuticals
SCPH
|
$25.5M |
| 2 |
KVSC
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
|
$24.5M |
| 3 |
TIOA
Tio Tech A Class A Ordinary Share
TIOA
|
$22.2M |
| 4 |
Stoke Therapeutics
STOK
|
$21.1M |
| 5 |
AAC
Ares Acquisition Corporation
AAC
|
$13.5M |
Top Sells
| 1 |
DCP
DCP Midstream, LP
DCP
|
$58.8M |
| 2 |
SCPL
SciPlay Corporation Class A Common Stock
SCPL
|
$26.1M |
| 3 |
Cantaloupe
CTLP
|
$12.3M |
| 4 |
KAIR
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
|
$8.76M |
| 5 |
Innoviz Technologies
INVZ
|
$8.61M |
Sector Composition
| 1 | Healthcare | 38.53% |
| 2 | Financials | 25.7% |
| 3 | Materials | 12.71% |
| 4 | Consumer Discretionary | 4.55% |
| 5 | Technology | 2.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Sylvamo
SLVM
$1.86B
| $99.5M | 11.68% | 2,150,000 | – | – |
|
2
Avidity Biosciences
RNA
$5.99B
| $70.5M | 8.28% | 4,592,966 +304,600 | +7% | +$4.68M |
|
3
Establishment Labs
ESTA
$1.2B
| $58.7M | 6.89% | 866,172 +9,518 | +1% | +$645K |
|
|
AVDL
4
Avadel Pharmaceuticals
AVDL
$1.43B
| $34.2M | 4.02% | 3,732,778 | – | – |
|
|
5
Stoke Therapeutics
STOK
$1.08B
| $27.3M | 3.21% | 3,279,142 +2,531,065 | +338% | +$21.1M |
|
|
6
scPharmaceuticals
SCPH
$295M
| $25.5M | 2.99% | +2,807,562 | New | +$25.5M |
|
|
KVSC
7
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $24.5M | 2.87% | +2,410,664 | New | +$24.5M |
|
8
Sumitomo Mitsui Financial
SMFG
$105B
| $22.4M | 2.63% | 2,800,730 -570,000 | -17% | -$4.56M |
|
|
TIOA
9
DELISTED
Tio Tech A Class A Ordinary Share
TIOA
| $22.2M | 2.6% | +2,176,071 | New | +$22.2M |
|
10
Immunocore
IMCR
$1.62B
| $20M | 2.35% | 405,174 | – | – |
|
11
Immunovant
IMVT
$2.56B
| $19.4M | 2.28% | 1,250,000 | – | – |
|
12
Rocket Pharmaceuticals
RCKT
$354M
| $18.8M | 2.21% | 1,100,000 | – | – |
|
13
Adicet Bio
ACET
$59.9M
| $18.1M | 2.13% | 3,143,608 | – | – |
|
14
Energy Transfer Partners
ET
$60.8B
| $17.3M | 2.03% | 1,384,500 -330,500 | -19% | -$4.12M |
|
|
15
Innoviz Technologies
INVZ
$335M
| $16.4M | 1.93% | 4,696,109 -2,460,281 | -34% | -$8.61M |
|
|
PEGR
16
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $15.3M | 1.8% | 1,500,000 | – | – |
|
|
HCVIU
17
DELISTED
Hennessy Capital Investment Corp. VI Unit
HCVIU
| $15.2M | 1.79% | 1,500,000 | – | – |
|
|
CCV
18
DELISTED
Churchill Capital Corp V
CCV
| $14.1M | 1.65% | 1,397,140 +1,248,295 | +839% | +$12.6M |
|
|
AAC
19
DELISTED
Ares Acquisition Corporation
AAC
| $13.5M | 1.58% | +1,304,228 | New | +$13.5M |
|
|
CVII
20
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $12.5M | 1.46% | 1,227,823 +942,823 | +331% | +$9.56M |
|
21
Amplify Junior Silver Miners ETF
SILJ
$1.98B
| $11.9M | 1.4% | 1,072,434 +437,805 | +69% | +$4.87M |
|
|
CUTR
22
DELISTED
Cutera, Inc.
CUTR
| $11.6M | 1.36% | 491,512 -179,797 | -27% | -$4.25M |
|
23
Coinbase
COIN
$78.2B
| $9.04M | 1.06% | 133,846 +97,371 | +267% | +$6.58M |
|
24
ODP
ODP
$610M
| $8.96M | 1.05% | 199,181 -5,000 | -2% | -$225K |
|
25
AdvisorShares Pure US Cannabis ETF
MSOS
$986M
| $8.92M | 1.05% | 1,568,280 +244,936 | +19% | +$1.39M |
|